Mark A. Velleca - 09 Aug 2021 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role
Director
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
Issuer symbol
BDTX
Transactions as of
09 Aug 2021
Net transactions value
$0
Form type
4
Filing time
11 Aug 2021, 16:58:17 UTC
Previous filing
15 Jul 2021
Next filing
10 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDTX Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 09 Aug 2021 Common Stock 30,000 $9.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in thirty-six (36) equal monthly installments following the Grant Date.